indirubin-3'-monoxime has been researched along with paclitaxel in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Chen, X; Goto, M; Lai, F; Lee, KH; Xiao, Z; Yan, L; Zhou, A | 1 |
Chen, BB; Chen, XB; Deng, WY; Han, LL; Li, N; Lü, HF; Luo, SX; Wang, XF | 1 |
4 other study(ies) available for indirubin-3'-monoxime and paclitaxel
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Design, synthesis and biological evaluation of novel indolin-2-ones as potent anticancer compounds.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Immunohistochemistry; Indoles; Molecular Structure; Structure-Activity Relationship | 2017 |
Molecular mechanism of indirubin-3'-monoxime and Matrine in the reversal of paclitaxel resistance in NCI-H520/TAX25 cell line.
Topics: Alkaloids; Blotting, Western; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Indoles; Inhibitor of Apoptosis Proteins; Matrines; Octamer Transcription Factor-3; Oximes; Paclitaxel; Quinolizines; SOXB1 Transcription Factors; Survivin | 2013 |